Literature DB >> 24484327

Dual inhibition of interleukin-1β and interleukin-18: a new treatment option for sepsis?

Steven M Opal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24484327     DOI： 10.1164/rccm.201312-2292ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

Review 1.  Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.

Authors:  Donato Rigante; Giacomo Emmi; Michele Fastiggi; Elena Silvestri; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-08       Impact factor: 3.650

2.  Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.

Authors:  Lena Heinbockel; Sebastian Marwitz; Sergio Barcena Varela; Raquel Ferrer-Espada; Norbert Reiling; Torsten Goldmann; Thomas Gutsmann; Walter Mier; Tobias Schürholz; Daniel Drömann; Klaus Brandenburg; Guillermo Martinez de Tejada
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

3.  A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock.

Authors:  Nuala J Meyer; Jane F Ferguson; Rui Feng; Fan Wang; Parth N Patel; Mingyao Li; Chenyi Xue; Liming Qu; Yichuan Liu; John H Boyd; James A Russell; Jason D Christie; Keith R Walley; Muredach P Reilly
Journal:  Am J Respir Crit Care Med       Date:  2014-09-15       Impact factor: 30.528

4.  Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia.

Authors:  Yao-Li Cui; Bing Wang; Hong-Mei Gao; Ying-Hong Xing; Jian Li; Hong-Jie Li; Zhu Lin; Yong-Qiang Wang
Journal:  Patient Prefer Adherence       Date:  2016-03-11       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.